Development of a sensitive and quantitative PD-L1 immunoassay superior to IHC with application in human FFPE tissue samples

被引：0
|
作者：
Wallweber, Gerald [1 ]
Chenna, Ahmed [1 ]
Ravanera, Roy [1 ]
Stathas, David [1 ]
Huang, Weidong [1 ]
Petropoulos, Christos [1 ]
机构：
[1] Monogram Biosci, San Francisco, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-LB-281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-281
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Concordance of PD-L1 expression detection in non-small cell lung cancer (NSCLC) tissue biopsies between OncoTect iO single cell PD-L1 quantification assay and immunohistochemistry (IHC).
    Chargin, Amanda
    Morgan, Rian Janine
    Patterson, Bruce Kendrick
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD-L1 Expression and Quantitative Tissue Analysis
    Wayne, Max T.
    Moulton, Nathaniel G.
    Weimholt, Cody
    Chenna, Praveen
    Chen, Alexander C.
    THORACIC CANCER, 2025, 16 (02)
  • [33] Development of a clinical trial assay for PD-L1 immunohistochemistry (IHC) for use with pembrolizumab (pembro) clinical trials in melanoma.
    Dolled-Filhart, Marisa
    Ebbinghaus, Scot
    Roach, Charlotte
    Ponto, Gary
    Toland, Grant
    Jansson, Malinka
    Emancipator, Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Multifunctional DNA scaffold mediated gap plasmon resonance: Application to sensitive PD-L1 sensor
    Mao, Zhihui
    Zheng, Wenjia
    Hu, Shiqi
    Peng, Xinsheng
    Luo, Yunhan
    Lee, Jaebeom
    Chen, Hongxia
    Biosensors and Bioelectronics, 2024, 247
  • [35] Multifunctional DNA scaffold mediated gap plasmon resonance: Application to sensitive PD-L1 sensor
    Mao, Zhihui
    Zheng, Wenjia
    Hu, Shiqi
    Peng, Xinsheng
    Luo, Yunhan
    Lee, Jaebeom
    Chen, Hongxia
    BIOSENSORS & BIOELECTRONICS, 2024, 247
  • [36] Analysis of PD-L1 IHC tests using NIST SRM 1934-traceable reference materials: A new paradigm for development of predictive IHC biomarkers.
    Torlakovic, Emina E.
    Sompuram, Seshi
    Vani, Kodela
    Bogen, Steve
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy
    Peng, Zhengyao
    Lu, Chang
    Shi, Guangyuan
    Yin, Lin
    Liang, Xiaolong
    Song, Guosheng
    Tian, Jie
    Du, Yang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (05) : 1291 - 1305
  • [38] Sensitive and quantitative in vivo analysis of PD-L1 using magnetic particle imaging and imaging-guided immunotherapy
    Zhengyao Peng
    Chang Lu
    Guangyuan Shi
    Lin Yin
    Xiaolong Liang
    Guosheng Song
    Jie Tian
    Yang Du
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1291 - 1305
  • [39] PD-L1 Expression in Various Tumor Types: A Tissue Microarray Study on 11,838 Tumor Samples
    Moeller, Katharina
    Knoell, Madeleine
    Blessin, Niclas
    Bady, Elena
    Mandelkow, Tim
    Lennartz, Maximilian
    Minner, Sarah
    Rico, Sebastian Dwertmann
    Kluth, Martina
    Fraune, Christoph
    Lebok, Patrick
    Contreras, Hendrina
    Weidemann, Soeren
    Gorbokon, Natalia
    Steurer, Stefan
    Burandt, Eike-Christian
    Sauter, Guido
    Simon, Ronald
    Marx, Andreas
    Krech, Till
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1557 - S1558
  • [40] Analytical comparison of a PD-L1 22C3 antibody LDT protocol on the BenchMark XT and PD-L1 IHC 22C3 pharmDx: Analysis of pan-tumor and esophageal cancer samples.
    Vainer, Gilad W.
    Zatara, Ghadeer
    Huang, Lingkang
    Emancipator, Kenneth
    Nuti, Shanthy
    CANCER RESEARCH, 2021, 81 (13)
12345